ASA Advocacy and 30-Day Mortality

Features| May 2024 ASA Advocacy and 30-Day Mortality Randall M. Clark, MD, FASA Randall M. Clark, MD, FASA Search for other works by this author on: This Site PubMed Google Scholar ASA Monitor May 2024, Vol. 88, 14. https://doi.org/10.1097/01.ASM.0001016808.18617.f8 Views Icon Views Article contents Figures ASA Advocacy and 30-Day Mortality. ASA Monitor 2024; 88:14 doi: https://doi.org/10.1097/01.ASM.0001016808.18617.f8 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll PublicationsASA Monitor Search Advanced Search Topics: advocacy, mortality Early in 2023, my colleagues from the Colorado Society of Anesthesiologists and I were sitting in Governor Jared Polis' office in the state capitol. The governor's office had notified us of his intention to extend to the entire state the limited 2010 rural opt-out from the Medicare requirement for physician supervision of nurse anesthetists. This was now the fourth time since 2003 we had to fight a full state opt-out in Colorado. It was clear the governor had already made up his mind on the issue. He had long supported expanding scope of practice for optometrists, pharmacists, physician assistants, and others. He listened to our arguments, but it was clear we were not changing his opinion. But he paused after one of our statements. I handed him data showing that Colorado was only in the middle of the pack on 30-day mortality after surgery. He thought for a minute and... You do not currently have access to this content.